These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23909005)

  • 41. The 'enigma' of Richard Schultes, Amazonian hallucinogenic plants, and the limits of ethnobotany.
    Sheldrake M
    Soc Stud Sci; 2020 Jun; 50(3):345-376. PubMed ID: 32375597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey.
    Perkins D; Opaleye ES; Simonova H; Bouso JC; Tófoli LF; GalvÃo-Coelho NL; Schubert V; Sarris J
    Drug Alcohol Rev; 2022 Jan; 41(1):265-274. PubMed ID: 34308566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies.
    Rodrigues LS; Rossi GN; Rocha JM; L Osório F; Bouso JC; Hallak JEC; Dos Santos RG
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):541-556. PubMed ID: 33914164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.
    Frecska E; Móré CE; Vargha A; Luna LE
    J Psychoactive Drugs; 2012; 44(3):191-9. PubMed ID: 23061318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Teacher plants - Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives.
    Berlowitz I; O'Shaughnessy DM; Heinrich M; Wolf U; Maake C; Martin-Soelch C
    J Ethnopharmacol; 2022 Mar; 286():114910. PubMed ID: 34933085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach.
    Franquesa A; Sainz-Cort A; Gandy S; Soler J; Alcázar-Córcoles MÁ; Bouso JC
    Psychiatry Res; 2018 Jun; 264():334-339. PubMed ID: 29674223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders.
    Renelli M; Fletcher J; Tupper KW; Files N; Loizaga-Velder A; Lafrance A
    Eat Weight Disord; 2020 Apr; 25(2):437-444. PubMed ID: 30474794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
    Doering-Silveira E; Grob CS; de Rios MD; Lopez E; Alonso LK; Tacla C; Da Silveira DX
    J Psychoactive Drugs; 2005 Jun; 37(2):141-4. PubMed ID: 16149326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life.
    Kaasik H; Kreegipuu K
    J Psychoactive Drugs; 2020; 52(3):255-263. PubMed ID: 32299306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.
    Bouso JC; González D; Fondevila S; Cutchet M; Fernández X; Ribeiro Barbosa PC; Alcázar-Córcoles MÁ; Araújo WS; Barbanoj MJ; Fábregas JM; Riba J
    PLoS One; 2012; 7(8):e42421. PubMed ID: 22905130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ayahuasca in adolescence: a preliminary psychiatric assessment.
    Da Silveira DX; Grob CS; de Rios MD; Lopez E; Alonso LK; Tacla C; Doering-Silveira E
    J Psychoactive Drugs; 2005 Jun; 37(2):129-33. PubMed ID: 16149324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.
    Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M
    Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.
    Halpern JH; Sherwood AR; Passie T; Blackwell KC; Ruttenber AJ
    Med Sci Monit; 2008 Aug; 14(8):SR15-22. PubMed ID: 18668010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The globalization of ayahuasca: harm reduction or benefit maximization?
    Tupper KW
    Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society.
    Blainey MG
    J Relig Health; 2015 Feb; 54(1):287-302. PubMed ID: 24477460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.
    Orsolini L; Chiappini S; Papanti D; Latini R; Volpe U; Fornaro M; Tomasetti C; Vellante F; De Berardis D
    Hum Psychopharmacol; 2020 May; 35(3):e2728. PubMed ID: 32220028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination.
    Jiménez-Garrido DF; Gómez-Sousa M; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    Sci Rep; 2020 Mar; 10(1):4075. PubMed ID: 32139811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.
    McKenna D; Riba J
    Curr Top Behav Neurosci; 2018; 36():283-311. PubMed ID: 28401525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
    Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
    Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ayahuasca and the traveller: A scoping review of risks and possible benefits.
    Houle SKD; Evans D; Carter CA; Schlagenhauf P
    Travel Med Infect Dis; 2021; 44():102206. PubMed ID: 34785376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.